Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins

E. M. Rego; L.-Z. He; R. P. Warrell; Z.-G. Wang; P. P. Pandolfi

Proceedings of the National Academy of Sciences of the United States of America (2000) - Comments
pubmed: 10954752 doi: 10.1073/pnas.180290497 issn: 0027-8424 issn: 1091-6490

E. M. Rego, L.-Z. He, R. P. Warrell, Z.-G. Wang, P. P. Pandolfi

Go to article

Proceedings of the National Academy of Sciences